Obtenir mon propre profil
Citée par
Toutes | Depuis 2019 | |
---|---|---|
Citations | 6086 | 4588 |
indice h | 32 | 27 |
indice i10 | 46 | 45 |
Accès public
Tout afficher47 articles
8 articles
disponibles
non disponibles
Sur la base des exigences liées au financement
Coauteurs
- Thomas TütingDepartment of Dermatology, University Hospital Magdeburg, GermanyAdresse e-mail validée de med.ovgu.de
- Michael HolzelInstitute of Experimental Oncology, University Hospital Bonn, Germany. Twitter: @IEO_HolzelLabAdresse e-mail validée de ukb.uni-bonn.de
- Mark J. SmythQIMR BerghoferAdresse e-mail validée de qimrberghofer.edu.au
- Nicole GloddeInstitute of Experimental Oncology, University Hospital Bonn. Twitter: IEO_GloddeLabAdresse e-mail validée de ukbonn.de
- Kyohei Nakamura M.D., Ph.D.Team Head, QIMR Berghofer Medical Research Institute, BrisbaneAdresse e-mail validée de qimrberghofer.edu.au
- Jasmin StraubeQIMR Berghofer Medical Research InstituteAdresse e-mail validée de qimrberghofer.edu.au
- Göran JönssonProfessor, Dept. of Oncology, Clinical Sciences, Lund University, SwedenAdresse e-mail validée de med.lu.se
- Veit HornungGene Center and Department of Biochemistry, Ludwig-Maximilians-University MunichAdresse e-mail validée de genzentrum.lmu.de
- Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalAdresse e-mail validée de sswahs.nsw.gov.au
- Georgina V LongMelanoma Institute Australia, The University of Sydney and Royal North Shore HospitalAdresse e-mail validée de sydney.edu.au
- Ulrich KalinkeInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and ClinicalAdresse e-mail validée de twincore.de
- Winfried BarchetOMass Therapeutics, VP ImmunologyAdresse e-mail validée de omass.com
- Nicola WaddellQIMR Berghofer Medical Research InstituteAdresse e-mail validée de qimrberghofer.edu.au
Suivre
Tobias Bald
Group Leader, Institute for experimental Oncology, University Hospital Bonn
Adresse e-mail validée de ukbonn.de - Page d'accueil